Arthritis Research UK is the resource for anyone looking for the latest news in the fight against arthritis. We’re providing answers today and tomorrow toward a future free from arthritis.
A maximum of 200 results have been returned
Ankylosing spondylitis and spondyloarthritis patients are more likely to be able to stick with anti-TNF treatment when receiving DMARD therapy at the same time, according to a new study.
Find out more
Remsima, a new and more affordable biosimilar version of the anti-TNF therapy Remicade, has been launched in the UK.
Assessing disease activity after three months can be a good way of predicting long-term clinical response rates among rheumatoid arthritis patients who are being treated with infliximab.
A new study has offered evidence that the presence of diabetes should be considered as a risk factor for knee osteoarthritis progression.
A new study has shown that osteoarthritis is more common in patients undergoing anterior cruciate ligament surgery, particularly in men.
Progressive high-impact jumping exercises can improve the cartilage quality of postmenopausal women who may be at risk of osteoporosis and osteoarthritis, according to a Finnish study.
Scientists have identified a promising molecule that blocks a key driver of inflammatory diseases, opening the door for new non-invasive treatments for arthritis, gout and other related diseases.
A new Swedish study has shown that sustained remission is an uncommon but persistent outcome among rheumatoid arthritis patients treated with anti-TNFs, while also shedding light on factors associated with greater treatment effectiveness.
A new Danish study has demonstrated that the elevated mortality risk in patients with osteoporosis can be mediated by successful treatment.
Rheumatoid arthritis patients in sustained remission can successfully taper or stop treatment with DMARDs without their disease relapsing, according to a study.